26413 | test post new | testuser | 02/14/2014 5:18:19 AM |
26412 | test reply | testuser | 02/14/2014 5:10:36 AM |
26410 | admin | testuser | 02/11/2014 11:54:01 PM |
26409 | Test post from testgt | testgt | 02/05/2014 9:34:37 AM |
26408 | test Post | testgt | 02/05/2014 8:10:10 AM |
26407 | New Post | itest | 02/05/2014 7:27:55 AM |
26406 | New test posty | itest | 02/05/2014 4:03:26 AM |
26405 | New post good aftre noon :) | itest | 02/05/2014 3:47:05 AM |
26404 | test post | itest | 02/05/2014 3:37:50 AM |
26403 | New post updates | itest | 02/04/2014 8:05:05 AM |
26401 | new Post | itest | 02/03/2014 7:11:31 AM |
26400 | Nice layout of post :) | itest | 02/03/2014 6:33:14 AM |
26399 | 10 Lorem Ipsum is simply dummy text of the | testuser | 02/01/2014 1:13:03 AM |
26398 | 9 Lorem Ipsum is simply dummy text of the | testuser | 02/01/2014 1:12:55 AM |
26396 | 7 Lorem Ipsum is simply dummy text of the | testuser | 02/01/2014 1:12:37 AM |
26395 | 6 Lorem Ipsum is simply dummy text of the | testuser | 02/01/2014 1:12:31 AM |
26391 | 5 Lorem Ipsum is simply dummy text of the | testuser | 02/01/2014 1:08:24 AM |
26390 | 4 Lorem Ipsum is simply dummy text of the | testuser | 02/01/2014 1:08:17 AM |
26389 | 3 Lorem Ipsum is simply dummy text of the | testuser | 02/01/2014 1:08:01 AM |
26388 | 2 Lorem Ipsum is simply dummy text of the | testuser | 02/01/2014 1:07:55 AM |
26387 | 1 Lorem Ipsum is simply dummy text of the | testuser | 02/01/2014 1:07:48 AM |
26386 | thats cool | testuser | 01/31/2014 3:27:17 PM |
26385 | testtt | testuser | 01/31/2014 3:27:04 PM |
26384 | testing | testuser | 01/31/2014 3:26:52 PM |
26382 | If we see half of the volume we saw yesterday, we | Spiceman | 01/31/2014 6:22:10 AM |
26381 | Hi | testuser | 01/23/2014 9:44:55 AM |
26380 | public reply | saurabh | 01/23/2014 8:21:30 AM |
26379 | test post new | saurabh | 01/23/2014 8:20:29 AM |
26378 | asdasdasd // >> | itest | 01/22/2014 1:58:14 AM |
26377 | bolded text | itest | 01/22/2014 1:55:40 AM |
26376 | jbjkkbjbkjbk // >> | itest | 01/22/2014 1:52:00 AM |
26373 | test | testuser | 01/21/2014 9:02:37 PM |
26372 | hi | testuser | 01/17/2014 5:58:57 AM |
26371 | testingnggn | testuser | 01/17/2014 5:58:30 AM |
26366 | test post | itest | 01/17/2014 2:49:35 AM |
26365 | test Post test post | itest | 01/17/2014 12:20:53 AM |
26364 | test Post test post | itest | 01/17/2014 12:20:37 AM |
26362 | test | testuser | 01/16/2014 6:17:56 PM |
26361 | testt | testuser | 01/16/2014 6:17:45 PM |
26360 | Test | testuser | 01/16/2014 11:31:58 AM |
26359 | test reply | itest | 01/16/2014 10:20:29 AM |
26358 | test post | itest | 01/16/2014 10:20:02 AM |
26356 | Test | testuser | 01/16/2014 8:33:50 AM |
26355 | testing | itest | 01/07/2014 4:47:08 AM |
26354 | hello new post | itest | 01/06/2014 9:13:46 AM |
26353 | zxcZXcZXc | itest | 01/06/2014 9:12:58 AM |
26352 | dsfsadfasdasdf | itest | 01/06/2014 9:10:41 AM |
26351 | test post | itest | 01/06/2014 8:05:12 AM |
26350 | test post by itest | itest | 01/03/2014 6:35:57 AM |
26349 | tttt | Pipa | 12/31/2013 1:57:55 PM |
Recent Articles
- Raymond James Secures $1.5 Billion in Senior Notes Offering
- How a $100 Investment in Morgan Stanley Has Grown Over Time
- Kindly MD Soars on QMMM’s Crypto Treasury Movements
- LifeMD Faces Lawsuit Over Financial Transparency Issues
- Celebrating the Importance of School Partnerships This Year
- C3.ai Faces Class Action Over Alleged Misleading Financial Claims
- Capital Southwest Corporation Unveils $350M Note Offering for 2030
- Celebrating Innovation in Chemical Engineering: 2025 Awards
- Innovative AI Partnership to Transform Pilot Training Experience
- Fossil Group, Inc. Launches Comprehensive Financing Initiatives
- PrimeEnergy Resources Corp Achieves Prestigious National Recognition
- Investigation Update on SoundHound AI, Inc. Shareholder Claims
- Fossil Group Launches Exciting Exchange Offer and Rights Offering
- Blue Bird's Decade of Success: A Journey Through Returns
- Understanding DuPont de Nemours’ Stock Value and P/E Ratio Trends
- Unlocking Revenue Potential: Insights from 'The RevOps Advantage'
- NexPoint Real Estate Finance Declares Series A Dividend Payment
- Texas Centers for Infectious Disease Associates Data Incident Update
- Investigation into Atkore Inc. Sparks Concerns Among Investors
- Methode Electronics Faces Investigation Amid Recent Complaints
- Investors Alert: Quanex Building Products Faces Legal Action
- Fly-E Group, Inc. Faces Class Action Lawsuit from Investors
- OneMove Capital Advocates for Change at Sylogist Ltd. to Restore Trust
- Pro Visionary Pty Ltd Enhances Asset Security for Investors
- Rocket Lab USA Inc Faces Legal Challenges Amid Performance Issues
- Investigation Announced for Regeneron Pharmaceuticals Amid Concerns
- Revance Therapeutics Under Investigation Amid Class Action Concerns
- Investing $100 in Howmet Aerospace: Growth Over 5 Years
- Activist Investors Take Center Stage with BILL Holdings
- Discovering the Last Decade's Growth of Motorola Solutions
- Fly-E Group, Inc. Faces Securities Investigation and Losses
- Investigation Launched for Fly-E Group, Inc. Investors
- Radiant Logistics Announces Upcoming Investor Call on Q4 Results
- OSR Holdings Addresses Trading Concerns Amid Nasdaq Notice
- Parkland Corporation Declares Dividend Policy for Investors
- Powerful Partnerships Launch Initiative for Bay Area Students
- Meredith Aronson Enhances Stagwell's Corporate Affairs Strategy
- Empowering Voices: Bleu Inkk's Groundbreaking One-Woman Show
- Key Issues Facing Maravai LifeSciences Holdings, Inc.
- Legal Inquiry into Centene Corporation: A Call to Action for Investors
- Compass Diversified Faces Class Action Lawsuit: What Investors Should Know
- Investors Urged to Act Following Savara Class Action Lawsuit
- Investigation into Zynex, Inc.: Issues Facing Shareholders
- Inspirato Secures $22 Million Investment to Enhance Structure
- Elevance Health's Shareholder Rights Investigation and Updates
- QMMM Holdings Limited Stock Update: Crypto Expansion Drive
- Parkland Corporation Declares Third Quarter Dividend for Shareholders
- Innovative Treatments Transforming Open-Angle Glaucoma Management
- Legal Insights on Legionnaires' Disease and Recent Outbreaks
- Introducing ROHM's Game-Changing Ultra-Compact Op Amp